NASH becomes MASH as medical experts replace stigmatizing "non-alcoholic" liver disease terminology with dignity-focused ...

The findings support the concept that excessive lipogenesis, rather than just fat delivery from other sources, is central to ...

Heidi Lobprise, DVM, DAVDC, discusses the benefits of addressing chronic periodontal disease in older animals by employing ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Apostle Dr. Kadmiel E.H. Agbelenyo, Founder and Leader of the Seventh Day Theocracy World Congregation, has called on ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

Hundreds are gathering to support research and education at the Liver Life Walk, an event inspiring hope through stories of ...

At DDW 2025, researchers presented their findings on the effects of MAFLD on outcomes of patients with hepatocellular carcinoma.

SaveHealth provides an in-depth look at cholesterol-fighting atorvastatin, its mechanism of action, clinical significance, ...

Metabolic-associated fatty liver disease is prevalent in children and adolescents with severe obesity, with higher insulin ...

Preliminary data from ongoing Phase 1/2 trials show BEAM-302 is well tolerated and achieves dose-dependent, durable ...